Founded in 1998, Autobio Diagnostics Co., Ltd has become one of the leading clinical diagnostics companies in China. Autobio specializes in research & development, production, marketing and service of clinical diagnostic products, including Immunoassay, Microbiology and biochemical products. Autobio provides comprehensive solutions for medical laboratories.
Autobio has been focusing on the common development of both reagents and instruments. Reagents products include Immunoassay, Biochemistry, Microbiology and IVD subdivision areas, and instruments include both fully automation and semi-automation instruments and systems.
As a leading innovation enterprise in Henan Province, Autobio has a national-recognized Enterprise Technology Center, several joint automated Immunoassay laboratories of national and local governments and Henan province IVD Engineering Research Center. Autobio has undertaken a number of major national, provincial and municipal science and technology projects, including two projects of “National 863 Program”.
Autobio upholds the tenet of ‘commitment to the popularity and improvement of medical laboratory technology for human health’ and strives to provide both cost-efficient and high-quality products to medical laboratories.
Autobio highly values the importance of products R&D and technological innovation and believes that R&D and innovation are the core competitiveness of a company. In recent years Autobio has been investing approximately 10% of its revenue on R&D. As a result, Autobio has become one of the most active players in launching new products with highly experienced R&D employees in IVD field.
Autobio has developed a strategy to provide cost-efficient and high-quality products to customers. Through technical cooperation with several international big players and construction of scientific R&D system and evaluation system, Autobio has established a system with GMP, ISO9001 and ISO13485 certifications and stable product performance.
Autubio takes ‘value creation for customers’ as its service concept and insists on proving service standards and value accretion for customers. Autobio has over 400 professional service engineers to provide timely and thoughtful technical services to customers across the country.
Autobio has a strong distribution network with thousands of distributors covering domestic market. The company has sales representatives in all major cities, which guarantees timely reaction to customers’ requests. Autobio has built up a strong brand recognition with its well-established distribution and customer services network. Autobio is constantly exploring new distribution channels and products. It works closely with distributors to explore new business models and has formed three major business lines that consist of Immunoassay, Biochemistry and Microbiology testing through merger and acquisition.
Autobio Diagnostics Co., Ltd. was listed on Shanghai Stock Exchange on September 1st, 2016 (603658, Autobio).
‘To become a well-known medical laboratory products and services provider to reward employees, investors, and society’ has been Autobio’s vision.